Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,418 public trials 3,293 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

Treatment of Pancreatic Cancer With Abraxane

NCT02555813

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • BHB Eisenstadt Eisenstadt, Austria
  • LKH Feldkirch Feldkirch, Austria
  • Medical University Graz Graz, Austria
  • Medical University Innsbruck Innsbruck, Austria
View all 19 locations
View Trial Details
Completed

Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")

NCT00391118

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liège, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Düsseldorf, Germany
View all 15 locations
View Trial Details
Completed

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

NCT02469480

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +18 more
Locations
  • Krankenhaus Nordwest gGmbH - Institut of Clinical Cancer Research Frankfurt am Main, Hesse, Germany
  • Klinikum Aschaffenburg Aschaffenburg, Germany
  • Klinikum Bayreuth Bayreuth, Germany
  • Augusta-Krankenanstalt gGmbH Bochum, Germany
View all 18 locations
View Trial Details
Completed

Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer

NCT00003862

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Foundation for Cancer Research and Education Phoenix, Arizona, United States
  • Mount Diablo Medical Center Concord, California, United States
  • Northridge Hospital Medical Center Northridge, California, United States
View all 55 locations
View Trial Details
Completed

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

NCT01337765

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States
  • University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States
  • Pfizer Investigative Site Parkville, Victoria, Australia
  • Pfizer Investigative Site Toronto, Ontario, Canada
View Trial Details
Completed

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

NCT02192333

Conditions
Behavior, Behavioral Symptoms, Bone Diseases, +40 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Completed

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

NCT02045602

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Hospital Vall d'Hebron Barcelona, Spain
  • Institut Català d'Oncologia L'Hospitalet de Llobregat, Spain
  • Centro Integral Oncológico Clara Campal Madrid, Spain
  • Hospital Universitario Ramón y Cajal Madrid, Spain
View Trial Details

Related conditions